| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis.
|
N Engl J Med
|
1985
|
11.94
|
|
2
|
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.
|
JAMA
|
1993
|
4.63
|
|
3
|
Cost-effectiveness of a routine varicella vaccination program for US children.
|
JAMA
|
1994
|
3.27
|
|
4
|
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta.
|
JAMA
|
1991
|
3.09
|
|
5
|
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
|
N Engl J Med
|
1995
|
2.81
|
|
6
|
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children.
|
Lancet
|
1991
|
2.64
|
|
7
|
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.
|
Clin Infect Dis
|
1992
|
2.55
|
|
8
|
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control.
|
Clin Infect Dis
|
1993
|
2.21
|
|
9
|
The Vaccine Adverse Event Reporting System (VAERS).
|
Vaccine
|
1994
|
2.02
|
|
10
|
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
|
JAMA
|
1985
|
1.91
|
|
11
|
Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex?
|
JAMA
|
1987
|
1.81
|
|
12
|
Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting.
|
JAMA
|
1992
|
1.74
|
|
13
|
Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance?
|
Pediatrics
|
1987
|
1.57
|
|
14
|
Epidemiological features of pertussis in the United States, 1980-1989.
|
Clin Infect Dis
|
1992
|
1.55
|
|
15
|
Comment: ethical dilemmas in worldwide polio eradication programs.
|
Am J Public Health
|
1997
|
1.44
|
|
16
|
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors.
|
J Pediatr
|
1986
|
1.40
|
|
17
|
Mumps outbreak in a highly vaccinated population.
|
J Pediatr
|
1991
|
1.30
|
|
18
|
Vaccine prevention of Haemophilus influenzae type b disease: past, present and future.
|
Pediatr Infect Dis
|
1986
|
1.27
|
|
19
|
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease.
|
Arch Pediatr Adolesc Med
|
1994
|
1.23
|
|
20
|
Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States.
|
Am J Epidemiol
|
1994
|
1.20
|
|
21
|
Disease eradication as a public health strategy: a case study of poliomyelitis eradication.
|
Bull World Health Organ
|
2000
|
1.18
|
|
22
|
Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984.
|
Am J Epidemiol
|
1990
|
1.18
|
|
23
|
Mumps transmission in hospitals.
|
Arch Intern Med
|
1990
|
1.14
|
|
24
|
National immunization days: state of the art.
|
J Infect Dis
|
1997
|
1.12
|
|
25
|
Measles eradication: is it in our future?
|
Am J Public Health
|
2000
|
1.12
|
|
26
|
Preventing rubella: assessing missed opportunities for immunization.
|
Am J Public Health
|
1987
|
1.11
|
|
27
|
Tetanus surveillance--United States, 1989-1990.
|
MMWR CDC Surveill Summ
|
1992
|
1.09
|
|
28
|
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection.
|
Am J Epidemiol
|
1994
|
1.09
|
|
29
|
A large outbreak of mumps in the postvaccine era.
|
J Infect Dis
|
1988
|
1.08
|
|
30
|
Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease.
|
JAMA
|
1988
|
1.07
|
|
31
|
Immunizations in college health: the remaining tasks.
|
J Am Coll Health
|
1987
|
1.06
|
|
32
|
Prevention of secondary transmission of pertussis in households with early use of erythromycin.
|
Am J Dis Child
|
1992
|
1.01
|
|
33
|
Pertussis surveillance--United States, 1989-1991.
|
MMWR CDC Surveill Summ
|
1992
|
1.01
|
|
34
|
Control of epidemic group A meningococcal meningitis in Nepal.
|
Int J Epidemiol
|
1987
|
0.98
|
|
35
|
Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis.
|
Clin Infect Dis
|
1993
|
0.97
|
|
36
|
Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.
|
JAMA
|
1985
|
0.96
|
|
37
|
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination.
|
Ann N Y Acad Sci
|
1995
|
0.96
|
|
38
|
Overview of neonatal listeriosis.
|
Clin Invest Med
|
1984
|
0.95
|
|
39
|
Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough.
|
Clin Infect Dis
|
1995
|
0.95
|
|
40
|
Changing epidemiology of mumps and its impact on university campuses.
|
Pediatrics
|
1989
|
0.93
|
|
41
|
Waving goodbye to measles.
|
Nature
|
2001
|
0.91
|
|
42
|
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases.
|
Am J Public Health
|
1989
|
0.89
|
|
43
|
Estimating national incidence of group B streptococcal disease: the effect of adjusting for birth weight.
|
Pediatr Infect Dis
|
1983
|
0.83
|
|
44
|
Mumps surveillance--United States, 1988-1993.
|
MMWR CDC Surveill Summ
|
1995
|
0.83
|
|
45
|
Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins.
|
J Infect Dis
|
1997
|
0.83
|
|
46
|
Measles, mumps, and rubella vaccines.
|
Infect Dis Clin North Am
|
1990
|
0.81
|
|
47
|
Prevention of Haemophilus influenzae type b infections in day care: a public health perspective.
|
Rev Infect Dis
|
1986
|
0.80
|
|
48
|
Major subtypes of invasive Haemophilus influenzae from 1983 to 1985 in Atlanta, Ga.
|
J Clin Microbiol
|
1990
|
0.79
|
|
49
|
Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan.
|
J Infect Dis
|
1997
|
0.79
|
|
50
|
Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman.
|
J Infect Dis
|
1992
|
0.79
|
|
51
|
Poliomyelitis eradication: progress, challenges for the end game, and preparation for the post-eradication era.
|
Infect Dis Clin North Am
|
2001
|
0.78
|
|
52
|
Effect of target age of supplemental immunization campaigns on poliomyelitis occurrence in China.
|
J Infect Dis
|
1997
|
0.78
|
|
53
|
Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
|
Pediatr Clin North Am
|
2000
|
0.77
|
|
54
|
Evidence against increasing rubella seronegativity among adolescent girls.
|
Am J Public Health
|
1990
|
0.77
|
|
55
|
Preventing polio from becoming a reemerging disease.
|
Emerg Infect Dis
|
2001
|
0.75
|
|
56
|
Current epidemiology of pertussis in the United States.
|
Tokai J Exp Clin Med
|
1988
|
0.75
|
|
57
|
Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of a new vaccine.
|
Am J Dis Child
|
1986
|
0.75
|
|
58
|
Poliomyelitis in the United States: a historical perspective and current vaccination policy.
|
J Am Coll Health
|
1990
|
0.75
|
|
59
|
A profile of mothers giving birth to infants with congenital rubella syndrome. An assessment of risk factors.
|
Am J Dis Child
|
1990
|
0.75
|